Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement safety, claim substantiation within commission's purview, members say.

This article was originally published in The Tan Sheet

Executive Summary

SUPPLEMENT SAFETY, CLAIM SUBSTANTIATION ADVICE WITHIN COMMISSION PURVIEW, President's Commission on Dietary Supplement Labels member Margaret Gilhooley, Seton Hall University School of Law, maintained at an Aug. 14 meeting in Reston, Va. The commission held a two-day meeting Aug. 14 and 15 to discuss the over 240 comments received on its draft report on supplement labeling and claims issued June 24 ("The Tan Sheet" June 30, pp. 17-25). The commission also discussed changes it will make in the final report, expected in the fall. One comment said the commission "exceeded its statutory authority" by addressing additional issues in the report such as safety, claim substantiation, statements of nutritional support, consumer research and research funding, Gilhooley noted.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087441

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel